PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma
Author(s) -
Hannah Dabagian,
Tahereh Taghvaee,
Paul Martorano,
Daniel Martínez,
Minu Samanta,
Carolyn M. Watkins,
Richard Chai,
Adam J. Mansfield,
Thomas J. A. Graham,
John M. Maris,
Daniel A. Pryma,
Robert H. Mach,
Mehran Makvandi
Publication year - 2021
Publication title -
acs pharmacology and translational science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.271
H-Index - 10
ISSN - 2575-9108
DOI - 10.1021/acsptsci.0c00206
Subject(s) - immune system , in vivo , combination therapy , cancer research , immunotherapy , immunology , pharmacology , medicine , biology , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom